Concepedia

Publication | Open Access

Dexamethasone Intravitreal Implant as Adjunctive Therapy to Ranibizumab in Neovascular Age-Related Macular Degeneration: A Multicenter Randomized Controlled Trial

42

Citations

35

References

2015

Year

Abstract

DEX reduced the need for adjunctive ranibizumab treatment and showed acceptable tolerability in nvAMD patients.

References

YearCitations

Page 1